BRA
MRK icon

Bender Robert & Associates’s Merck MRK Stock Holding History

Bender Robert & Associates’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$490K Sell
4,077
-360
-8% -$41.6K 0.12% 33
2025
Q4 		$467K Sell
4,437
-375
-8% -$35.2K 0.1% 31
2025
Q3 		$404K Sell
4,812
-100
-2% -$8.24K 0.09% 36
2025
Q2 		$389K Sell
4,912
-20
-0.4% -$1.59K 0.09% 35
2025
Q1 		$443K Sell
4,932
-50
-1% -$4.67K 0.11% 32
2024
Q4 		$496K Hold
4,982
– – 0.12% 33
2024
Q3 		$566K Buy
+4,982
New +$592K 0.12% 33
2024
Q2 		– Sell
-6,663
Closed -$858K – 70
2024
Q1 		$879K Sell
6,663
-60
-0.9% -$7.39K 0.21% 30
2023
Q4 		$733K Sell
6,723
-243
-3% -$25.2K 0.18% 31
2023
Q3 		$717K Sell
6,966
-550
-7% -$59.3K 0.21% 31
2023
Q2 		$867K Sell
7,516
-936
-11% -$106K 0.24% 31
2023
Q1 		$899K Sell
8,452
-140
-2% -$15.1K 0.28% 31
2022
Q4 		$953K Hold
8,592
– – 0.36% 32
2022
Q3 		$740K Buy
8,592
+880
+11% +$78.6K 0.29% 37
2022
Q2 		$703K Hold
7,712
– – 0.27% 37
2022
Q1 		$633K Buy
7,712
+1,270
+20% +$100K 0.18% 38
2021
Q4 		$484K Hold
6,442
– – 0.14% 40
2021
Q3 		$484K Buy
6,442
+50
+0.8% +$3.8K 0.14% 42
2021
Q2 		$497K Sell
6,392
-212
-3% -$15.8K 0.14% 43
2021
Q1 		$486K Hold
6,604
– – 0.16% 39
2020
Q4 		$516K Hold
6,604
– – 0.16% 36
2020
Q3 		$523K Hold
6,604
– – 0.19% 36
2020
Q2 		$487K Sell
6,604
-179
-3% -$13.5K 0.19% 35
2020
Q1 		$498K Sell
6,783
-73
-1% -$5.74K 0.27% 35
2019
Q4 		$595K Sell
6,856
-5
-0.1% -$411 0.27% 35
2019
Q3 		$551K Buy
6,861
+162
+2% +$13K 0.28% 34
2019
Q2 		$521K Sell
6,699
-84
-1% -$6.43K 0.25% 35
2019
Q1 		$538K Buy
6,783
+110
+2% +$8.23K 0.26% 36
2018
Q4 		$487K Sell
6,673
-21
-0.3% -$1.48K 0.28% 36
2018
Q3 		$453K Hold
6,694
– – 0.21% 38
2018
Q2 		$388K Buy
6,694
+32
+0.5% +$1.8K 0.2% 38
2018
Q1 		$346K Sell
6,662
-157
-2% -$8.48K 0.19% 38
2017
Q4 		$366K Sell
6,819
-105
-2% -$5.82K 0.2% 38
2017
Q3 		$423K Sell
6,924
-42
-0.6% -$2.55K 0.24% 37
2017
Q2 		$426K Sell
6,966
-273
-4% -$16.6K 0.26% 38
2017
Q1 		$439K Sell
7,239
-125
-2% -$7.58K 0.28% 38
2016
Q4 		$414K Buy
7,364
+35
+0.5% +$2.05K 0.29% 38
2016
Q3 		$436K Buy
7,329
+126
+2% +$7.37K 0.29% 37
2016
Q2 		$396K Sell
7,203
-681
-9% -$36.2K 0.28% 39
2016
Q1 		$398K Sell
7,884
-5
-0.1% -$245 0.27% 40
2015
Q4 		$398K Buy
7,889
+707
+10% +$35.6K 0.25% 40
2015
Q3 		$338K Buy
7,182
+1,404
+24% +$74.6K 0.23% 39
2015
Q2 		$314K Sell
5,778
-63
-1% -$3.53K 0.19% 43
2015
Q1 		$320K Buy
5,841
+341
+6% +$19.3K 0.19% 41
2014
Q4 		$298K Buy
5,500
+220
+4% +$12.3K 0.2% 45
2014
Q3 		$299K Sell
5,280
-164
-3% -$9.21K 0.21% 45
2014
Q2 		$301K Sell
5,444
-456
-8% -$24.9K 0.21% 45
2014
Q1 		$320 Buy
5,900
+199
+3% +$10.3K 0.21% 43
2013
Q4 		$272K Buy
5,701
+52
+0.9% +$2.38K 0.2% 48
2013
Q3 		$257K Buy
5,649
+84
+2% +$3.83K 0.2% 49
2013
Q2 		$247K Buy
+5,565
New +$249K 0.21% 49

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bender Robert & Associates's MRK Position: Q1 2026 in Review

Bender Robert & Associates reduced its Merck (MRK) stake by 8.1% in Q1 2026, selling an estimated $41.6K and leaving 4,077 shares worth $490K. The position accounts for 0.12% of the portfolio, ranked #33.

Bender Robert & Associates first reported a position in MRK in Q2 2013 and has held it in 51 quarters since. The position peaked at $953K in Q4 2022. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Bender Robert & Associates held 4,077 shares of Merck worth $490K as of Q1 2026.
  • Bender Robert & Associates sold 360 Merck shares in Q1 2026, an estimated $41.6K.
  • Merck made up 0.12% of Bender Robert & Associates's portfolio in Q1 2026, its #33 holding.
  • Bender Robert & Associates first reported a position in Merck in Q2 2013 and has held it in 51 quarters since.
  • Bender Robert & Associates's Merck position peaked at $953K in Q4 2022.
  • 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Bender Robert & Associates's 13F filing for Q1 2026, filed 23 Apr 2026.